Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexplanon vs Oral Contraceptive for Painful Endometriosis
NCT02669238Phase 3Terminated
- Sponsor
- CHU de La Réunion
- Start
- May 2018
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of etonogestrel in endometriosis (2 arms), sponsored by CHU de La Réunion. Primary endpoint: Global satisfaction at 6 months. Started May 2018; status: terminated.
02
Drugs
etonogestrel
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02669238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669238.